Rheumatoid Arthritis News

Development of rheumatoid arthritis, or another such inflammatory disease, often brings with it a mental toll.

Physical function and MRI scores predict flares at 6 and 12 months following the end of treatment with abatacept among patients with early rheumatoid arthritis in remission, according to data published in Arthritis Research & Therapy.

Glucocorticoids can do a lot of harm over time. In this episode, John Stone, MD, MPH, walks us through the Glucocorticoid Toxicity Index, a validated tool to measure steroid toxicity over time that we’ll be seeing more of in the future.

Social determinants of health, including food insecurity, are prevalent among adults with self-reported rheumatoid arthritis, according to a study published in BMC Rheumatology.

The benefits of statins in reducing cardiovascular disease and mortality “outweigh” the associated increased risk for type 2 diabetes in patients with rheumatoid arthritis, according to data published in Arthritis Care & Research.

In patients with rheumatoid arthritis initiating either TNF inhibitors or non-TNF inhibitor biologic therapies, severe obesity and low BMI each impeded treatment response, according to data published in Arthritis Care & Research.

The American College of Rheumatology and the American Association of Hip and Knee Surgeons have released updated recommendations for the perioperative management of antirheumatic medication in patients undergoing hip and knee arthroplasty.

Nintedanib slows the rate of forced vital capacity decline in patients with fibrosing autoimmune disease-related interstitial lung disease, with adverse events manageable for most, according to data published in Arthritis & Rheumatology.

Treatment with baricitinib reduced mortality in critically ill patients with COVID-19 receiving invasive mechanical ventilation or extracorporeal membrane oxygenation, researchers reported in The Lancet Respiratory Medicine.

Lack of antibody response following COVID-19 vaccination is the strongest predictor of breakthrough infection in patients with autoimmune rheumatic disease, according to data published in Annals of the Rheumatic Diseases.